Stability of cervical specimens in surepath medium for human papillomavirus testing with the roche cobas 4800 assay

Journal of Clinical Microbiology

Volumn 51, Issue 10, 2013, Pages 3412-3414

  Gilbert, Laura ^a   Oates, Elizabeth ^a   Ratnam, Samuel ^b  

^a Newfoundland and Labrador Public Health Laboratory   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANALYZER; ARTICLE; ASSAY; AUTOMATION; CLINICAL PROTOCOL; COLPOSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; ENVIRONMENTAL TEMPERATURE; FREEZING; GENOTYPE; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; VIRUS DETECTION;

CERVIX UTERI; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 84884755475     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01391-13     Document Type: Article

References (16)

1. Castle PE, Stoler MH, Wright MH, Jr, Sharma A, Wright TL, Behrens CM. 2011. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 12:880-890.
2. Clad A, Reuschenbach M, Weinschenk J, Grote R, Rahmsdorf J, Freudenberg N. 2011. Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology. J. Clin. Microbiol. 49:1071-1076.
3. Mateos Lindemann ML, Sanchez Calvo JM, Chacon de Antonio J, Sanz I, Rubio MD, de la Morena ML. 2011. Prevalence and distribution of high-risk genotypes of HPV in women with severe cervical lesions in Madrid, Spain: importance of detecting genotype 16 and other high-risk genotypes. Adv. Prev. Med. 2011:269468.
4. Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, Giede C, Lear A. 2010. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer J. Clin. Microbiol. 48:2779-2785.
5. Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, Giede C, Lear A. 2011. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 assay but more specific at detecting cervical precancer and cancer J. Clin. Microbiol. 49: 557-564.
6. Wright TC, Jr, Stoler MH, Sharma A, Zhang G, Behrens C, Wright TL, Athena Study Group. 2011. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am. J. Clin. Pathol. 136:578-586.
7. Roche Molecular Systems. 2010. cobas 4800 HPV test, for in vitro diagnostic use: package insert. Roche Molecular Systems, Pleasanton, CA.
8. Moelans CB, Oostenrijk D, Moons MJ, van Diest PJ. 2011. Formaldehyde substitute fixatives: effects on nucleic acid preservation. J. Clin. Pathol. 64:960-967.
9. Naryshkin S, Austin RM. 2012. Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening. Drug Heathc. Patient Saf. 4:167-172.
10. Roche Molecular Systems. 2012. cobas 4800 HPV test, for in vitro diagnostic use: package insert. Roche Molecular Systems, Pleasanton, CA.
11. Stoler MH, Wright TC, Jr, Sharma A, Apple R, Gutekunst K, Wright TL, Athena Study Group HPV. 2011. High-risk human papillomavirus testing in women with ASC-US cytology, results from the ATHENA HPV study. Am. J. Clin. Pathol. 135:468-475.
12. Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC, Jr, Cuzick J, Athena Study Group HPV. 2012. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18. Am. J. Obstet. Gynecol. doi:10.1016/j.ajog.2012.11.020.
13. Heideman DAM, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJG, Fransen Daalmeijer N, Verkuijten M, Meijer CJLM, Snijders PJF. 2011. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 49:3983-3985.
14. Wong AA, Fuller J, Pabbaraju K, Wong S, Zahariadis G. 2011. Comparison of the Hybrid Capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J. Clin. Microbiol. 50:25-29.
15. Ki EY, Kim HE, Choi YJ, Park JS, Kang CS, Lee A. 2013. Comparison of the cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test. Int. J. Med. Sci. 10:119-123.
16. Gage JC, Sadorra M, LaMere BJ, Kail R, Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M, Castle PE, PaP Cohort Study Group. 2011. Comparison of the cobas human papillomavirus (HPV) test with the Hybrid Capture 2 and Linear ArrayHPVDNAtests. J. Clin. Microbiol. 50:61-65.